The overzealous FDA

Matthew Mintz: “It is harder to admit to that a profitable pharmaceutical industry is necessary in order to see innovative products. In addition, if the FDA (due to its intense recent scrutiny) is going to be overly cautious about every side effect, companies may choose not to develop products which huge potential gain for many because of some minimal side effects to a few.”

Prev
Next

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT